Zydus Cadila has sought regulatory approval for clinical trials of its antibody cocktail to treat mild COVID-19, as India grapples with a shortage of medicines and vaccines needed to effectively...

from NDTV News - Topstories https://ift.tt/3yAhyIu
https://ift.tt/eA8V8J